M. L. Simoons - Concepedia

Author

M. L. Simoons

Also Known As

A. H. J. Danser, M L Simoons, M SIMOONS, M. L Simoons, M. L. SIMOONS, M. L. Simoons, M. Simoons, M.L. SIMOONS, M.L. Simoons, Maarten L Simoons

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Erasmus University Rotterdam Rotterdam University of Applied Sciences

About

M. L. Simoons is an author at Erasmus University Rotterdam specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.6K
2	Emergency Medicine	4	4	1.4K
3	Public Health	2	2	739
4	Health Sciences	1	1	20
5	Applied Physiology	1	1	20

M. L. Simoons

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial M. L. Simoons The Lancet Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseEarly Coronary RevascularisationGusto Iv-acs	2001	697
THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY M. L. Simoons The Lancet Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseCoronary Artery DiseaseFibrinolysis	1988	660
Ventricular free wall rupture: sudden, subacute, slow, sealed and stabilized varieties K. Balakumaran, C J Verbaan, C. E. Essed, European Heart Journal	1984	75
Recombinant tissue-type plasminogen activator and immediate angioplasty in acute myocardial infarction. One-year follow-up. The European Cooperative Study Group. Alfred Arnold, M. L. Simoons, Frans Van de Werf, Circulation	1992	69
Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study Andrew Briggs, Borislava Mihaylova, Mark Sculpher, Heart	2006	64
The additional value of patient-reported health status in predicting 1-year mortality after invasive coronary procedures: a report from the Euro Heart Survey on Coronary Revascularisation Mattie Lenzen, Wilma J.M. Scholte op Reimer, Susanne S. Pedersen, Heart	2006	52
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes. Eugene Braunwald, A Maseri, Paul W. Armstrong, PubMed Unstable AnginaCardiovascular PharmacologyPharmacotherapyCoronary Artery DiseaseAcute Myocardial Infarction	1998	42
Indirect enzyme-linked immunosorbent assay for immunoglobulin G and four immunoassays for immunoglobulin M to Toxoplasma gondii in a series of heart transplant recipients J. F. Sluiters, Aggie H.M.M. Balk, C. E. Essed, Journal of Clinical Microbiology TransplantationTransplantation MedicineImmunologyPathologySerologic Testing	1989	36
Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS Jan Paul Ottervanger, Paul W. Armstrong, E.S. Barnathan, European Heart Journal	2004	36
Long-term survival after successful out-of-hospital resuscitation G.P. Kimmana, E.M.A. Ivensa, J.A.M. Hartman, Resuscitation Trauma ResuscitationCardiopulmonary ResuscitationMedicinePatient SafetyLong-term Survival	1994	33

Page 1